Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilcox, P.
Right arrow Articles by Pardy, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wilcox, P.
Right arrow Articles by Pardy, R.

Chest, Vol 93, 352-358, Copyright © 1988 by American College of Chest Physicians

ARTICLES

Phrenic nerve function in patients with diaphragmatic weakness and systemic lupus erythematosus

PG Wilcox, HB Stein, SD Clarke, PD Pare and RL Pardy
University of British Columbia Pulmonary Research Laboratory, Vancouver, Canada.

Diaphragmatic weakness has been identified as one of the pulmonary manifestations of systemic lupus erythematosus. Whether this weakness results from a neuropathic or myopathic process has not been established. Thirty patients with SLE were screened for the presence of inspiratory muscle (IM) weakness. Detailed studies were performed in nine with IM weakness. All nine were found to have diaphragmatic weakness (mean +/- SD, maximal transdiaphragmatic pressure 50 +/- 12 cmH2O). Phrenic nerve latencies, evaluated using transcutaneous stimulation, were normal in all individuals excluding a demyelinating neuropathy. Compound diaphragm action potential (CDAP) with phrenic nerve stimulation was normal in six of these nine patients. Reduced CDAP in three of nine patients was consistent either with axonal degeneration of the phrenic nerve or diaphragm myopathy. Nerve conduction and electromyographic studies on peripheral nerves and muscles respectively failed to demonstrate an associated generalized neuropathy or myopathy. We conclude that diaphragmatic weakness in patients with SLE is both common and is very unlikely to be caused by a phrenic neuropathy.


This article has been cited by other articles:


Home page
 LupusHome page
K T.M Oud, P Bresser, R J M t. Berge, and R E Jonkers
The shrinking lung syndrome in systemic lupus erythematosus: improvement with corticosteroid therapy
Lupus, December 1, 2005; 14(12): 959 - 963.
[Abstract] [PDF]

Home page
 LupusHome page
R Omdal, P Roos, K Wildhagen, and R Gunnarsson
Respiratory arrest in systemic lupus erythematosus due to phrenic nerve neuropathy
Lupus, October 1, 2004; 13(10): 817 - 819.
[Abstract] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
F. Laghi and M. J. Tobin
Disorders of the Respiratory Muscles
Am. J. Respir. Crit. Care Med., July 1, 2003; 168(1): 10 - 48.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K. Hardy, I. Herry, V. Attali, J. Cadranel, and T. Similowski
Bilateral Phrenic Paralysis in a Patient With Systemic Lupus Erythematosus
Chest, April 1, 2001; 119(4): 1274 - 1277.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. A. Mills
Systemic Lupus Erythematosus
N. Engl. J. Med., June 30, 1994; 330(26): 1871 - 1879.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American College of Chest Physicians.